- Home
- XFOR vs XYF Comparison
XFOR vs XYF Comparison
Compare XFOR & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | XYF |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.5M | 260.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | XFOR | XYF |
|---|---|---|
| Price | $3.76 | $6.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $28.50 | N/A |
| AVG Volume (30 Days) | ★ 475.3K | 238.4K |
| Earning Date | 11-05-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 9.68% |
| EPS Growth | N/A | ★ 49.84 |
| EPS | N/A | ★ 5.72 |
| Revenue | $33,979,000.00 | ★ $1,106,908,607.00 |
| Revenue This Year | $1,266.01 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.01 |
| Revenue Growth | ★ 2925.74 | 47.14 |
| 52 Week Low | $1.35 | $5.44 |
| 52 Week High | $24.43 | $20.36 |
Technical Indicators
Market Signals| Indicator | XFOR | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 40.08 |
| Support Level | $3.57 | $5.68 |
| Resistance Level | $3.78 | $6.22 |
| Average True Range (ATR) | 0.20 | 0.29 |
| MACD | -0.04 | 0.11 |
| Stochastic Oscillator | 27.94 | 32.43 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.